<DOC>
	<DOCNO>NCT02188641</DOCNO>
	<brief_summary>Psoriatic arthritis ( PsA ) particular pattern inflammatory arthritis often see association psoriasis . PsA patient higher prevalence comorbidities include obesity , metabolic syndrome , depression premature cardiovascular disease . There evidence obesity associate PsA . A 12 month study conduct determine whether exercise dietary weight loss efficacious , either separately combination , standard care alone improve symptom sign obese adult PsA . Fifty-five obese PsA patient body mass index ( BMI ) ≥30 , recruit . Patients randomize usual lifestyle ( control ) , diet , exercise , diet plus exercise group 12 month . Disease activity assess . Blood sample collect 12 hour overnight fast analysed glucose , lipid profile , ESR , hsCRP , proinflammatory cytokine ; tumour necrosis factor alpha ( TNF-alpha ) , interleukin-6 ( IL-6 ) interleukin-17 ( IL-17 ) . The primary outcome measure include improvement ACR20 . Secondary endpoint include reduction PASI score , DAS28-CRP response physician patient global assessment ( PGA ) . Safety tolerability also assess . Data collect baseline every 6 month .</brief_summary>
	<brief_title>Effect Exercise Diet Psoriatic Arthritis</brief_title>
	<detailed_description>There evidence obesity associate PsA . Obesity lead increase proinflammatory cytokine may contribute development multiple disturbance PsA patient . A 12 month , randomize single blind clinical trial conduct determine whether long-term exercise dietary weight loss efficacious , either separately combination , standard care alone improve physical function , pain , fatigue , depression systemic inflammation obese adult PsA . Fifty-five obese ethnically homogenous adult PsA patient body mass index ( BMI ) ≥30 , satisfied classification psoriatic arthritis criterion recruit . Patients randomize usual lifestyle ( control ) , diet , exercise , diet plus exercise group together continue use standard treatment . Exclusion criterion include inflammatory condition . Detailed skin rheumatological assessment conduct . Disease activity assess psoriasis area severity index ( PASI ) , disease activity score ( DAS28CRP ) , Health Assessment Questionnaire- Disability Index ( HAQ-DI ) , Beck 's Depression Inventory ( BDI ) fatigue numeric rating scale . Blood sample collect 12 hour overnight fast analysed glucose , lipid profile , ESR , hsCRP , proinflammatory cytokine ; tumour necrosis factor alpha ( TNF-alpha ) , interleukin-6 ( IL-6 ) interleukin-17 ( IL-17 ) . The primary outcome measure include improvement ACR20 , systemic inflammation marker , BMI , physical function , pain , fatigue , depression HAQ-DI . Secondary endpoint include reduction PASI score , DAS28-CRP response physician patient global assessment ( PGA ) . Safety tolerability also assess . Data collect baseline every 6 month .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<criteria>PsA patient body mass index ( BMI ) ≥30 Must satisfy classification psoriatic arthritis criterion Other inflammatory condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Psoriatic arthritis</keyword>
	<keyword>inflammation</keyword>
	<keyword>obesity</keyword>
	<keyword>diet</keyword>
	<keyword>exercise</keyword>
</DOC>